Severe coagulation factor V deficiency associated with an interstitial deletion of chromosome 1q Severe FV deficiency (Mendelian Inheritance in Man *227400) is a rare coagulation disorder that confers a variable bleeding risk, with a prevalence in the general population of approximately one in 1 000 000. The disorder can be further classified as either type I or type II deficiency, with either very low or more moderately reduced FV antigen levels, respectively, both of which are accompanied by reduced procoagulant activity [2][3][4]. Spanning more than 80 kb, the F5 gene is comprised of 25 exons and maps to chromosome 1q23 [5]. Genetic mutations underlying a FV-deficient hemorrhagic diathesis have been described in a limited number of cases and display considerable allelic heterogeneity. Most of the described cases have been due to point mutations in F5 [1,6].Here, we report a novel molecular etiology for FV deficiency in a 15-year-old girl with psychomotor delay, anatomic central nervous system abnormalities, and a solitary left kidney -all features consistent with a congenital 1q deletion syndromewho was found to have severely reduced plasma FV activity during a routine preoperative laboratory evaluation prior to an elective spinal stabilization surgery.The proband, a 15-year-old girl, underwent medical assessment prior to corrective surgery for progressive spinal scoliosis. According to her mother, the girl had experienced no previous abnormal bleeding tendencies. Preoperative testing revealed a mildly prolonged prothrombin time (13.2 s; normal 8.4-12 s; her International Normalized Ratio 1.3) and activated partial thromboplastin time (38 s; normal 21-33 s). She had undergone several minor surgical procedures in the past including placement of tympanostomy tubes and the insertion of a gastrostomy tube, which occurred without significant bleeding. Family members were also clinically unaffected. The patient and her mother consented to further investigations of her condition, in the context of a protocol approved by the Institutional Review Board of Mayo Clinic.Routine plasma-mixing studies and coagulation factor activity assays were performed in the Mayo Clinic Special Coagulation Laboratory. Factor V procoagulant activity assays were performed using FV-deficient plasma (Cryocheck, Precision Biologic Inc., Dartmouth, Nova Scotia, Canada) dropped onto microscope slides and checked by phase contrast microscopy to verify appropriate cellularity. Samples were then subjected to standard fluorescent in-situ hybridization (FISH) pretreatment and fluorescence microscopy methods using a probe covering the FV gene and the more telomeric HPC1 gene as a control.After isolation of genomic DNA from the patient with a resin-based DNA extraction kit, amplification of 25 FV exons was achieved by the polymerase chain reaction (PCR) using paired intronic primers. All PCR primers and conditions are available at http://www.stanford.edu/~zehnder. Products generated by PCR were sequenced using automated fluorescent dye-chemistry m...